IHM

Iguana Healthcare Management Portfolio holdings

AUM $133M
1-Year Est. Return 45.66%
This Quarter Est. Return
1 Year Est. Return
+45.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$23.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1 +$5.58M
2 +$2.1M
3 +$1.99M
4
AKCA
Akcea Therapeutics Inc
AKCA
+$1.74M
5
PBYI icon
Puma Biotechnology
PBYI
+$1.73M

Top Sells

1 +$5.61M
2 +$4.53M
3 +$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

1 Healthcare 82.78%
2 Energy 0.61%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
51
Voyager Therapeutics
VYGR
$209M
$830K 0.54%
50,000
+25,000
MRNS
52
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$816K 0.53%
25,000
-18,750
AKAO
53
DELISTED
Achaogen Inc
AKAO
$806K 0.52%
75,000
+45,000
ADVM
54
DELISTED
Adverum Biotechnologies
ADVM
$700K 0.46%
+20,000
OMED
55
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$615K 0.4%
150,000
-200,000
CCXI
56
DELISTED
ChemoCentryx, Inc.
CCXI
$595K 0.39%
100,000
-175,000
SCYX icon
57
SCYNEXIS
SCYX
$27.3M
$580K 0.38%
25,000
WMGI
58
DELISTED
Wright Medical Group Inc
WMGI
$444K 0.29%
+20,000
ASXC
59
DELISTED
Asensus Surgical, Inc.
ASXC
$241K 0.16%
+9,615
AET
60
DELISTED
Aetna Inc
AET
-28,500
RXDX
61
DELISTED
Ignyta, Inc.
RXDX
-125,000
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
-20,000
OBSV
63
DELISTED
ObsEva SA Ordinary Shares
OBSV
-50,000
XLRN
64
DELISTED
Acceleron Pharma
XLRN
-70,000
ALXN
65
DELISTED
Alexion Pharmaceuticals
ALXN
-40,000
ESRX
66
DELISTED
Express Scripts Holding Company
ESRX
-25,000
ADAP
67
DELISTED
Adaptimmune Therapeutics
ADAP
-25,000
ASND icon
68
Ascendis Pharma
ASND
$12.6B
-30,000
CAH icon
69
Cardinal Health
CAH
$50.5B
-30,000
EXEL icon
70
Exelixis
EXEL
$11.8B
0
KYNB
71
Kyntra Bio, Inc. Common Stock
KYNB
$37M
-1,600
FOLD icon
72
Amicus Therapeutics
FOLD
$4.43B
-60,000
GKOS icon
73
Glaukos
GKOS
$6.91B
-100,000
INSM icon
74
Insmed
INSM
$34.4B
-50,000
KURA icon
75
Kura Oncology
KURA
$736M
-90,000